Multiple sclerosis (MS) is a disease in which the immune system attacks the protective sheath (myelin) that covers the nerves. Myelin damage disrupts communication between your brain and the rest of your body. For myelin damage caused by MS, we use intravenous infusions of mesenchymal stem cells to possibly decrease symptoms and even show changes in MRIs.
Stem cell therapy is in the experimental stage for MS, and it’s important for people to have the best available information to understand this exciting area of research and make the best decisions related to this complex issue. Here at PRSC, we look forward to providing you with the most up-to-date information on the studies being performed and the progress being made with the introduction of mesenchymal stem cell therapy. We promote a healthy lifestyle with our treatments to better aid in your recovery and to allow the best possible outcome for you.